Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure

NCT ID: NCT04549142

Last Updated: 2023-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2023-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to study the effects of air pollution toxicants on pregnant mothers' immune health during and after pregnancy.

Using already collected samples, this study proposes to evaluate changes in immune function in response to air pollution with the use of innovative technologies, to identify the drivers of immune dysfunction and potential modifiable factors, and to determine how these immune findings are associated with pollution exposure and outcomes of disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Air Pollution Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women- high level pollution

Exposed to high levels of pollution (PM2.5)

There is no intervention

Intervention Type OTHER

There is no intervention

Pregnant women- low level pollution

Exposed to low levels of pollution (PM2.5)

There is no intervention

Intervention Type OTHER

There is no intervention

Non-pregnant women-high level pollution

Exposed to high levels of pollution (PM2.5)

There is no intervention

Intervention Type OTHER

There is no intervention

Non-pregnant women-low level pollution

exposed to low levels of pollution (PM2.5)

There is no intervention

Intervention Type OTHER

There is no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

There is no intervention

There is no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women: at 18-25 weeks gestation at time of eligibility screening and baseline visit

Exclusion Criteria

* Having smoked more than 50 cigarettes during pregnancy
* A history of autoimmune diseases, HIV or cancer
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Environmental Health Sciences (NIEHS)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

R. Sharon Chinthrajah

Associate Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

R. Sharon Chinthrajah, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford, Sean N Parker Center for Allergy and Asthma Center at Stanford

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sean N. Parker Center for Allergy & Asthma Research at Stanford University

Palo Alto, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01ES032253

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-56622

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.